Marlon O'neil Brathwaite, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1852 Ashburn Dr, Goshen, IN 46526 Phone: 574-533-5808 Fax: 574-534-7215 |
Neha Batra, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1852 Ashburn Dr, Goshen, IN 46526 Phone: 574-533-5808 |
Matthew R Misner, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 213 Middlebury St, Goshen, IN 46528 Phone: 574-534-3300 Fax: 574-534-5412 |
Dr. Natalie Kurtz, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1852 Ashburn Dr, Goshen, IN 46526 Phone: 574-533-5808 |
Dr. Glenn B Stoltzfus, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1345 Somerset Ct, Goshen, IN 46528 Phone: 574-534-1813 |
Mrs. Kehinde Animashaun, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1852 Ashburn Dr, Goshen, IN 46526 Phone: 574-533-5808 Fax: 574-534-7215 |
Tiffany Lahr, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1852 Ashburn Dr, Goshen, IN 46526 Phone: 574-533-5808 Fax: 574-534-7215 |
News Archive
New research led by Costas D. Maranas from The Pennsylvania State University predicts amino acid changes to the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein would negatively impact binding affinity and subsequent infection into human cells.
Increasing the amount of time spent asleep immediately after a traumatic experience may ease any negative consequences, suggests a new study conducted by researchers at Washington State University's Elson S. Floyd College of Medicine.
Bioconnect Systems, Inc. announced today that data from the Company's first clinical study will be presented this week at the ASN Meeting in San Diego. Bioconnect's implant platform, the Optiflowâ„¢, enhances a surgeon's ability to create precise vascular connections.
The Michael J. Fox Foundation for Parkinson's Research today announced $1.1 million in total funding to six different projects aimed at validating potential therapeutic targets for Parkinson's disease.
› Verified 9 days ago